Evidence map›Paper›PMID 28824942›Full record

ReviewBladder cancer (Amsterdam, Netherlands)2017

Image-Guided Transurethral Resection of Bladder Tumors - Current Practice and Future Outlooks.

Timothy C Chang, Gautier Marcq, Bernhard Kiss, Dharati R Trivedi, Kathleen E Mach, Joseph C Liao

Open access · hybridAbstract readReview
In one paragraph

Review in Bladder cancer (Amsterdam, Netherlands), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Frontiers in oncology · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2019
    Article
  13. Review
  14. Active surveillance for non-muscle invasive bladder cancer.Translational andrology and urology · 2019
    Review
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Timothy C ChangDepartment of Urology, Stanford University School of Medicine, Stanford, CA, USA.
Gautier MarcqDepartment of Urology, Stanford University School of Medicine, Stanford, CA, USA.
Bernhard KissDepartment of Urology, Stanford University School of Medicine, Stanford, CA, USA.
Dharati R TrivediDepartment of Urology, Stanford University School of Medicine, Stanford, CA, USA.
Kathleen E MachDepartment of Urology, Stanford University School of Medicine, Stanford, CA, USA.
Joseph C LiaoDepartment of Urology, Stanford University School of Medicine, Stanford, CA, USA.
VA Palo Alto Health Care System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transurethral resection of bladder tumor (TURBT) under white light cystoscopy (WLC) is the cornerstone for the diagnosis, removal and local staging of non-muscle invasive bladder cancer (NMIBC). Despite technological improvements over the decades, significant shortcomings remain with WLC for tumor detection, thereby impacting the surgical quality and contributing to tumor recurrence and progression. Enhanced cystoscopy modalities such as blue light cystoscopy (BLC) and narrow band imaging (NBI) aid resections by highlighting tumors that might be missed on WLC. Optical biopsy technologies such as confocal laser endomicroscopy (CLE) and optical coherence tomography (OCT) characterize tissue in real-time to ensure a more thorough resection. New resection techniques, particularly en bloc resection, are actively under investigation to improve the overall quality of resections and aid pathologic interpretation. Moreover, new image processing computer algorithms may improve perioperative planning and longitudinal follow-up. Clinical translation of molecular imaging agents is also on the horizon to improve optical diagnosis of bladder cancer. This review focuses on emerging technologies that can impact the quality of TURBT to improve the overall management of NMIBC.

Indexed as

antigens CD47computer-assistedconfocal microscopycystoscopyhexaminolevulinic acidlaser surgerymolecular imagingnarrow band imagingoptical coherence tomographyUrinary bladder neoplasms

Identifiers

PMID28824942
PMCPMC5545914
OpenAlexW2741069988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.